Treatment-Resistant Depression (TRD)

SPRAVATO® Benefits: The Science of Hope for Treatment-Resistant Depression

Woman holding coffee mug.

For patients struggling with treatment-resistant depression (TRD), finding relief can feel like chasing a distant dream. Traditional oral antidepressants, while effective for many, don’t work for everyone. That’s where SPRAVATO, a groundbreaking esketamine nasal spray, steps in—a revolutionary treatment designed to address depression in a fundamentally different way. SPRAVATO is FDA-approved to treat depression in SPRAVATO® Benefits: The Science of Hope for Treatment-Resistant Depression

Advances in the Treatment of Depression

Advances in the Treatment of Depression

Depression is a pervasive mental health condition that affects millions of people worldwide. Characterized by persistent feelings of sadness, hopelessness, and a lack of interest or pleasure in daily activities, depression can be debilitating and disrupt every aspect of a person’s life.

Breaking the Stigma: New Advances in the Treatment of Major Depressive Disorder

Major depressive disorder is a pervasive mood disorder that’s got folks feeling down in the dumps worldwide. It’s also referred to as clinical depression or simply depression and lasts for a minimum of two weeks with symptoms of low mood or hopelessness.

Breaking Point: Covid-19 Pandemic Sparks 25% Increase in Global Anxiety and Depression

Who would’ve thought a tiny virus could wreak havoc on our mental health? According to the World Health Organization (WHO), the first year of the COVID-19 pandemic saw a whopping 25% increase in global anxiety and depression.

we want to hear from you

Is Spravato® Right for You?